David J. A. Goldsmith

David J. A. Goldsmith's AcademicInfluence.com Rankings

Philosophy

#9245

World Rank

#12779

Historical Rank

Logic

#6232

World Rank

#7733

Historical Rank

philosophy Degrees

Download Badge

Philosophy

David J. A. Goldsmith's Degrees

Doctorate Medicine University of Oxford
PhD Nephrology University of Oxford

Why Is David J. A. Goldsmith Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David J. A. Goldsmith's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. (2013) (348)
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (328)
Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. (1997) (239)
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. (2009) (217)
Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease (2014) (193)
Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. (2004) (184)
Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. (2004) (177)
Vascular calcification in chronic kidney disease. (2010) (174)
Nephrotic syndrome in adults (2008) (174)
An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. (1997) (172)
Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? (2004) (161)
Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness (2012) (150)
Monocyte subpopulations and cardiovascular risk in chronic kidney disease (2012) (149)
Arterial stiffness in renal patients: an update. (2005) (148)
Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min). (2015) (140)
Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. (2005) (138)
Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. (2004) (136)
Active vitamin D treatment for reduction of residual proteinuria: a systematic review. (2013) (136)
Use of phosphate-binding agents is associated with a lower risk of mortality. (2013) (135)
The double challenge of resistant hypertension and chronic kidney disease (2015) (134)
Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. (2005) (131)
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders. (2014) (128)
Illness representations and quality of life scores in haemodialysis patients. (2004) (126)
Assessment and management of hypertension in transplant patients. (2015) (122)
Posttransplantation Anemia in Adult Renal Allograft Recipients: Prevalence and Predictors (2006) (116)
Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms. (2000) (113)
Infective endocarditis in dialysis patients: new challenges and old. (2003) (113)
Pulmonary hypertension in CKD. (2013) (113)
Multimodal management of urolithiasis in renal transplantation (2005) (112)
Thrombotic Micro‐Angiopathy with Sirolimus‐Based Immunosuppression: Potentiation of Calcineurin‐Inhibitor‐Induced Endothelial Damage? (2003) (112)
Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome? (2014) (109)
Coronary artery disease in uremia: Etiology, diagnosis, and therapy. (2001) (109)
Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients (2003) (108)
Increased arterial stiffness in children on haemodialysis. (2006) (108)
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. (2010) (108)
Progression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level? (1998) (107)
Bone alkaline phosphatase in CKD-mineral bone disorder. (2013) (105)
Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. (2014) (101)
Adynamic bone disease: from bone to vessels in chronic kidney disease. (2014) (101)
PTH--a particularly tricky hormone: why measure it at all in kidney patients? (2013) (100)
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. (2017) (99)
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights. (2012) (99)
Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients (2014) (98)
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study (2012) (97)
Echocardiographic findings in long-term, long-hour hemodialysis patients. (1996) (94)
Rifampicin-induced acute renal failure: a series of 60 patients. (1998) (89)
A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. (2003) (89)
Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease (2010) (89)
Cardiac calcification in renal patients: what we do and don't know. (2004) (87)
Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: A prospective, crossover study (2012) (87)
Magnesium in Chronic Kidney Disease: Challenges and Opportunities (2010) (86)
Assessing glycemic control in patients with diabetes and end-stage renal failure. (2003) (85)
Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension? (2015) (84)
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. (2014) (84)
Aerobic or Resistance Training and Pulse Wave Velocity in Kidney Transplant Recipients: A 12-Week Pilot Randomized Controlled Trial (the Exercise in Renal Transplant [ExeRT] Trial). (2015) (82)
Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. (2002) (81)
Anemia after renal transplantation. (2006) (81)
COSMOS: the dialysis scenario of CKD-MBD in Europe. (2013) (80)
Sirolimus‐Induced Pneumonitis: Three Cases and a Review of the Literature (2004) (78)
Ambulatory blood pressure monitoring in renal dialysis and transplant patients. (1997) (77)
Allergic reactions to the polymeric glucose-based peritoneal dialysis fluid icodextrin in patients with renal failure (2000) (76)
Focus on renal congestion in heart failure (2015) (75)
Anaemia in diabetic patients with chronic kidney disease—prevalence and predictors (2006) (74)
Phosphate – The Silent Stealthy Cardiorenal Culprit in All Stages of Chronic Kidney Disease (2009) (73)
Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. (1996) (72)
Renal Anemia of Inflammation: The Name Is Self-Explanatory (2011) (70)
Interdialysis blood pressure control by long haemodialysis sessions. (1996) (70)
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. (2002) (69)
Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome. (2017) (68)
Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised? (2006) (68)
Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care (2018) (67)
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. (2008) (67)
Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week. (2019) (66)
Cardiovascular disease in chronic kidney disease: untying the Gordian knot (2013) (65)
Serum Vitamin D Levels Are Independently Associated With Severity of Coronary Artery Disease (2012) (62)
Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias. (2000) (62)
Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate (2008) (61)
The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies (2010) (60)
Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients. (2000) (60)
Successful medical treatment of acute bilateral emphysematous pyelonephritis. (2000) (59)
Sudden Death in Hemodialysis: An Update (2010) (59)
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia (2016) (58)
Important causes of hypoglycaemia in patients with diabetes on peritoneal dialysis (2001) (57)
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? (2014) (57)
Association between the malnutrition-inflammation score and post-transplant anaemia. (2011) (57)
The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda (2011) (56)
Vascular calcification and bone mineral density in recurrent kidney stone formers. (2015) (55)
Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients (2004) (55)
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. (2013) (55)
Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion (2003) (55)
Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data (2013) (52)
The challenge of cardiovascular risk factors in end-stage renal disease. (2003) (52)
Vitamin D metabolites and/or analogs: which D for which patient? (2013) (51)
Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease (2011) (50)
Allopurinol, uric acid, and oxidative stress in cardiorenal disease (2011) (49)
Circulating markers of bone turnover (2017) (49)
Pro: cardiovascular calcifications are clinically relevant. (2015) (49)
Page kidney--a review of the literature. (2003) (48)
Anaemia, microcytosis and sirolimus--is iron the missing link? (2010) (47)
Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? (2011) (47)
Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? (2016) (47)
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis (2012) (46)
The Influence of Dialytic Modality on Arterial Stiffness, Pulse Wave Reflections, and Vasomotor Function (2004) (45)
News on biomarkers in CKD-MBD. (2014) (45)
Ambulatory blood pressure monitoring in nephrology: focus on BP variability. (1999) (45)
Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) – A systematic review and meta-analysis (2017) (45)
Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria? (1999) (42)
The Effects of Vitamin D Therapy on Left Ventricular Structure and Function – Are These the Underlying Explanations for Improved CKD Patient Survival? (2010) (42)
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study. (2014) (42)
Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat. (2003) (41)
Prevalence and Management of Anaemia in Renal Transplant Recipients: Data from Ten European Centres (2010) (41)
Differential Effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. (2002) (40)
Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury (2017) (39)
Diabetic nephropathy: What does the future hold? (2015) (39)
A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern Network on Adverse Reactions (SONAR) (2012) (39)
Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). (2011) (39)
Direct renin inhibitors: the dawn of a new era, or just a variation on a theme? (2007) (37)
Long-hours home haemodialysis--the best renal replacement therapy method? (1999) (37)
Dynamics of the Circadian Blood Pressure Profiles after Renal Transplantation (2005) (37)
Management of atrial fibrillation in chronic kidney disease: double trouble. (2013) (36)
Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study (2011) (36)
Pro: Should we correct vitamin D deficiency/insufficiency in chronic kidney disease patients with inactive forms of vitamin D or just treat them with active vitamin D forms? (2016) (36)
The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone. (1998) (36)
What we CAN do about chronic allograft nephropathy: role of immunosuppressive modulations. (2005) (35)
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia. (2015) (35)
New immunosuppressive therapies in renal transplantation: monoclonal antibodies. (2005) (35)
Aspergillus endophthalmitis: an unusual complication of disseminated infection in renal transplant patients. (2003) (35)
Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients? (2003) (34)
Diabetes, kidney disease and anaemia: time to tackle a troublesome triad? (2007) (34)
New options for the anemia of chronic kidney disease (2017) (34)
Mammalian Target of Rapamycin (mTOR) Inhibitors (2011) (34)
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD. (2009) (34)
2009: a requiem for rHuEPOs--but should we nail down the coffin in 2010? (2010) (33)
Haemodialysis acutely improves endothelium-independent vasomotor function without significantly influencing the endothelium-mediated abnormal response to a beta 2-agonist. (2004) (32)
Septic arthritis due to extended spectrum beta lactamase producing Klebsiella pneumoniae. (2007) (32)
Post-transplantation anaemia in adult and paediatric renal allograft recipients-Guy's Hospital experience. (2006) (32)
Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients. (2004) (32)
Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes. (2004) (31)
From Finland to fatland: beneficial effects of statins for patients with chronic kidney disease. (2004) (30)
Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure. (2003) (30)
Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up (2012) (29)
Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation (2004) (29)
Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). (2008) (29)
Regression of vascular calcification in chronic kidney disease – feasible or fantasy? A review of the clinical evidence (2012) (29)
Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes. (2015) (29)
Low-Dose Mycophenolate Mofetil is an Effective and Safe Treatment to Permit Phased Reduction in Calcineurin Inhibitors in Chronic Allograft Nephropathy (2005) (29)
Is it time for spironolactone therapy in dialysis patients? (2006) (28)
Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation. (2006) (28)
Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution. (2002) (28)
Intravenous iron therapy in renal failure: friend and foe? (2004) (28)
Phosphodiesterase type 5 inhibitors and kidney disease (2015) (28)
Long-term pulse wave velocity outcomes with aerobic and resistance training in kidney transplant recipients – A pilot randomised controlled trial (2017) (27)
Calciphylaxis, thrombotic diathesis and defects in coagulation regulation. (1997) (27)
Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3-5. (2012) (26)
18F-fluoride Positron Emission Tomography Measurements of Regional Bone Formation in Hemodialysis Patients with Suspected Adynamic Bone Disease (2013) (26)
Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis? (1995) (26)
Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience? (2018) (25)
Ambulatory blood pressure monitoring: an essential tool for blood pressure assessment in uraemic patients. (2002) (25)
Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease (2018) (25)
Reversible acute renal failure induced by losartan in a renal transplant recipient. (1997) (25)
Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence. (2009) (24)
Urea kinetic modelling--are any of the 'bedside' Kt/V formulae reliable enough? (1998) (24)
The uses and abuses of Vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD). (2014) (24)
Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective. (2011) (24)
How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure? (2002) (24)
Negative outcome studies in end-stage renal disease: how dark are the storm clouds? (2007) (23)
Mineral and bone disorder after renal transplantation: a review (2007) (23)
Statins in chronic kidney disease and kidney transplantation. (2014) (23)
Renal Association Clinical Practice Guideline on Cardiovascular Disease in CKD (2011) (23)
Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients. (2003) (23)
Vitamin D and osteoporosis in chronic kidney disease (2017) (23)
The metabolic syndrome following kidney transplantation. (2010) (22)
Intradialytic changes in reflective properties of the arterial system during a single hemodialysis session (2005) (22)
Erythropoiesis-Stimulating Agents (ESA) for Preventing the Progression of Chronic Kidney Disease: A Meta-Analysis of 19 Studies (2014) (22)
Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement. (2015) (22)
Mineral metabolism and vitamin D in chronic kidney disease—more questions than answers (2011) (21)
Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD (2018) (21)
Determinants of vitamin D status in long‐term renal transplant patients (2012) (21)
Have we reached the limits for the treatment of diabetic nephropathy? (2014) (21)
The complexity of the cardio–renal link: taxonomy, syndromes, and diseases (2011) (21)
Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era. (2012) (21)
Vasculitis and rapidly progressive glomerulonephritis in the elderly. (1996) (21)
Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease (2015) (20)
Parathyroid carcinoma in a dialysis patient. (2000) (20)
Stimulating Erythropoiesis: Future Perspectives (2008) (19)
Pulmonary Wegener's granulomatosis misdiagnosed as malignancy (2001) (19)
Systolic Blood Pressure Diurnal Variation is Not a Predictor of Renal Target Organ Damage in Kidney Transplant Recipients (2004) (19)
Oxford textbook of clinical nephrology (2015) (18)
The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidney disease and mild chronic renal impairment--a prospective ABPM study. (2002) (18)
Reversible nephrotic syndrome due to mesangiocapillary glomerulonephritis secondary to hepatic hydatid disease. (1996) (18)
An economic evaluation of sevelamer in patients new to dialysis. (2008) (18)
The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD). (2013) (18)
Beneficial effects of statins on the kidney: the evidence moves from mouse to man. (2004) (18)
Renal Failure with Granulomatous Interstitial Nephritis and Diffuse Leukemic Renal Infiltration in Chronic Lymphocytic Leukemia (2007) (18)
Magnesium-based interventions for normal kidney function and chronic kidney disease. (2016) (18)
Effect of renin–angiotensin–aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis (2018) (18)
Renal arterial intervention and angiotensin blockade in atherosclerotic nephropathy. (2000) (18)
Complete clinical remission and subsequent relapse of bronchiectasis-related (AA) amyloid induced nephrotic syndrome. (1996) (17)
Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes (2010) (17)
Brain-kidney cross-talk: Definition and emerging evidence. (2016) (17)
The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients (2017) (16)
Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA). (2010) (16)
Twenty-one years survival with systemic AL-amyloidosis. (1996) (16)
An economic evaluation of sevelamer in patients new to dialysis (2008) (16)
Glomerular filtration rate in prospective living kidney donors (2013) (15)
Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma (2001) (15)
Sudden Cardiac Death in Patients with Chronic Kidney Disease: Prevention Is the sine qua non (2011) (15)
Limitations of the peritoneal equilibration test in prescribing and monitoring dialysis therapy. (1995) (15)
Maintenance of adequate dialysis in a patient with peritoneal calcification using tidal peritoneal dialysis. (1998) (15)
Rectus sheath haematomata in patients with renal disease. (2002) (15)
Secondary oxalosis and sperm granuloma of the epididymis. (1994) (14)
The epidemics of cardiovascular disease in elderly patients with chronic kidney disease – Two facets of the same problem (2006) (14)
Vitamin K status in chronic kidney disease: a report of a study and a mini-review (2013) (14)
The use of echocardiography in observational clinical trials: the EURECA-m registry. (2013) (14)
4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism (2007) (13)
Three 'Pages' in a chapter of accidents. (2003) (13)
Ambulatory blood pressure measurement in the renal patient (2002) (13)
Calcifying panniculitis or 'simple' inflammation? Biopsy is better than a bone scan. (1997) (13)
Comparison of estimated GFR and measured GFR in prospective living kidney donors (2014) (13)
Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease. (2018) (13)
Blood pressure control in CKD stage 5D patients--are we more or less certain what to do in 2009? (2009) (13)
Diabetic muscle infarction: an unusual cause of acute limb swelling in patients on hemodialysis. (2003) (13)
Bleeding in advanced CKD patients on antithrombotic medication – A critical appraisal (2017) (13)
Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients. (2005) (13)
Endoluminal brushing of blocked permanent indwelling haemodialysis catheters saves money. (1997) (13)
What is the role of ambulatory BP monitoring in pediatric nephrology? (2004) (12)
An Unusual Pyridine Nucleotide Accumulating in Erythrocytes: Its Identity, and Positive Correlation with Degree of Renal Failure (2004) (12)
Statins and kidney disease: is the study of heart and renal protection at the cutting edge of evidence? (2012) (12)
Treating paracetamol overdose by charcoal haemoperfusion and long-hours high-flux dialysis. (1996) (12)
Bilateral popliteal aneurysms complicating adult polycystic kidney disease in a patient with a marfanoid habitus (2003) (12)
Long-term safety and efficacy of renin–angiotensin blockade in atherosclerotic renal artery stenosis (2012) (11)
Relationships between blood pressure variability and left ventricular parameters in haemodialysis and renal transplant patients (1998) (11)
Facet joint osteomyelitis in a patient on long-term hemodialysis. (2000) (11)
Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems (2011) (11)
Opponent's comments. (2015) (11)
Clinical imaging of vascular disease in chronic kidney disease (2016) (11)
Anaemia after Renal Transplantation – Role of Immunosuppressive Drugs and a Pathophysiological Appraisal (2006) (11)
Interrupting the natural history of diabetes mellitus: lifestyle, pharmacological and surgical strategies targeting disease progression. (2014) (11)
A clinical description of rifampicin-induced acute renal failure in 170 consecutive cases. (2004) (11)
Prevalence and predictors of abdominal aortic calcification in healthy living kidney donors (2013) (10)
Cinacalcet for cardiovascular disease in patients undergoing dialysis. (2013) (10)
Familial Juvenile Hyperuricaemic Nephropathy is not Such a Rare Genetic Metabolic Purine Disease in Britain (2006) (10)
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study (2013) (10)
Calibrating the impact of dual RAAS blockade on the heart and the kidney – balancing risks and benefits (2016) (10)
Impact of vitamin D on cardiac structure and function in chronic kidney disease patients with hypovitaminosis D: a randomized controlled trial and meta-analysis (2019) (9)
Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe (2010) (9)
Cerivastatin monotherapy-induced muscle weakness, rhabdomyolysis and acute renal failure. (2003) (9)
Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study (2017) (9)
The role of inflammation in acute coronary syndromes: review of the literature. (2004) (9)
Nomenclature in nephrology: preserving ‘renal’ and ‘nephro' in the glossary of kidney health and disease (2021) (9)
Routine Bioimpedance-Derived Volume Assessment for All Hypertensives: A New Paradigm (2014) (8)
HYPERTENSION IN HEMODIALYSIS PATIENTS: Ambulatory Blood Pressure Monitoring in Hemodialysis Patients: A Critique and Literature Review (2004) (8)
Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point? (2008) (8)
Lesson of the Week: Acute swollen legs due to rhabdomyolysis: initial management as deep vein thrombosis may lead to acute renal failure (1994) (8)
Reversible nephrotic syndrome due to mesangiocapillary glomerulonephritis secondary to hepatic hydatid disease (1996) (8)
Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease (2012) (8)
Recent insights from studies using ambulatory blood pressure monitoring in patients with renal disease (2003) (7)
Post-transplant lymphoproliferative disorder (PTLD) presenting as painful lymphocele 12 years after a cadaveric renal transplant (2008) (7)
Negative Outcome Studies in End-Stage Renal Disease (2008) (7)
Analysis of blood pressure variability derived from ambulatory blood pressure monitoring in 92 uraemic patients. (1996) (7)
B Cell Post Transplant Lymphoproliferative Disorder Complicating Solid Organ Transplantation (B-PTLD): A Single Centre Review Reporting 1) Results with Chemo-Immunotherapy (CHOP/R) and 2) the Predictive Ability of FDG-PET Scanning To Correlate with Long Term Overall Survival. (2005) (7)
GTP Concentrations are Elevated in Erythrocytes of Renal Transplant Recipients when Conventional Immunosuppression is Replaced by the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolic Acid Mofetil (MMF) (2004) (7)
Chronic overdose of leflunomide inducing interstitial nephritis. (2004) (7)
Current dilemmas in inhibiting the renin–angiotensin system: do not forget real life (2007) (7)
Meta-analysis of the effects of treating blood pressure on cardiovascular outcomes of dialysis patients. (2009) (7)
Late allograft loss due to recurrence of p-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis. (2001) (7)
Best approaches in the battle against Globesity? Learning lessons from our experience tackling HIV-AIDS and tobacco smoking (2012) (7)
Thrombophilia of nephrotic syndrome in adults. (2009) (7)
Chronic Allograft Nephropathy (CAN) - An Update (2008) (7)
Oral phosphate binders in CKD - is calcium the (only) answer? (2014) (7)
Bleeding post coronary artery bypass surgery. Clopidogrel--cure or culprit? (2006) (7)
Rebuttal: the case for routine parathyroid hormone monitoring. (2013) (6)
Staghorn calculi complicating renal transplantation in patients with persistent post-transplantation hyperparathyroidism. (2003) (6)
Clinical Features and Manifestations of CKD-MBD (2012) (6)
Parathyroid hormone measurements, guidelines statements and clinical treatments: a real-world cautionary tale (2012) (6)
The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? (2011) (6)
Dialysis-related beta-2-microglobulin amyloidosis after long-term dialysis, and the effect of renal transplantation and cyclosporin therapy. (1996) (6)
Should CAPD be the first choice for dialysis in Romania? Audit of the Iasi 'C. I. Parhon' Dialysis Center: 1995-2000. (2001) (5)
What added value does ambulatory blood pressure monitoring brings to the management of post renal transplantation hypertension? (2003) (5)
From Profusion to Confusion: The Saga of Managing Hypertension in Chronic Kidney Disease! (2015) (5)
Oncogenic mechanisms in renal insufficiency (2020) (5)
Tuberculosis complicating tertiary hyperparathyroidism in a patient with end-stage renal disease: a case report. (2008) (5)
Life-threatening rectal bleeding due to cytomegalovirus colitis in a haemodialysis patient (2009) (5)
Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries. (2014) (5)
The management of end-stage heart failure and reducing the risk of cardiorenal syndrome. (2013) (5)
SPRINT: The Study Nephrologists Might Take With a Grain of Salt (2016) (5)
Calcium and the saga of the binders: accumulating controversy, or building consensus? (2008) (5)
Opinion: The Case Against Routine Screening for Vascular Calcification in Chronic Kidney Disease (2010) (5)
Milk-alkali syndrome with metastatic calcification. (1996) (5)
A Systematic Literature Review on the Epidemiology and Economic Burden of Anaemia Associated with Chronic Kidney Disease (2013) (5)
Significant further evidence to bolster the link between epoetin and strokes in chronic kidney disease and cancer. (2011) (5)
Novel Multivalent Wound-Healing Ointment Provides Bioburden Control and Moisture Management: A Retrospective Registry Data Analysis (2016) (4)
Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study (2019) (4)
Renal and Urological Disorders Associated With Inflammatory Bowel Disease. (2022) (4)
Cardio-renal clinical challenges / (2015) (4)
Kidney disease 1 Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (4)
Treating stones in transplanted kidneys. (2013) (4)
Does diurnal variation in blood pressure exist in CAPD patients? (1994) (4)
Jupiter or Aurora? Micro-inflammation and dyslipidaemia: twin targets for statin therapy in CKD (2010) (4)
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients. (2018) (4)
HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience (2017) (4)
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study) (2015) (4)
Ambulatory blood pressure measurements in chronic kidney disease: ready to (rock and) roll? (2011) (4)
Persistent Post-Transplant Autonomous Hyperparathyroidism despite 23 Years of Excellent Renal Allograft Function (2001) (3)
Prolonged slow dialysis and better survival. (2000) (3)
The prevalence of electrocardiographic early repolarization in an adult cohort with chronic kidney disease and its impact upon all-cause mortality and progression to dialysis (2013) (3)
Promoting scientific collaboration and education in cardiovascular–renal medicine (2009) (3)
CVD in CKD: Focus on the Dyslipidemia Problem (2014) (3)
Faculty Opinions recommendation of Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. (2008) (3)
The battle against obesity: lessons from tobacco (2011) (3)
Vascular and arterial calcification in peritoneal dialysis patients--state-of-the-art 2012. (2012) (3)
Chronic renal allograft dysfunction: the evidence for a change in immunosuppression. (2006) (3)
Sudden death of a patient with polycystic kidneys due to acute inferior vena cava thrombosis (2016) (3)
Rectus sheath haematoma (2001) (3)
Factors affecting circulating mRNA for nephrin. (2005) (3)
Impact of seasonality on the dynamics of native Vitamin D repletion in long-term renal transplant patients (2017) (3)
How reproducible is diurnal blood pressure rhythm in patients with secondary (renal) hypertension? (1999) (2)
Medical and Surgical Management (Including Diet) (2012) (2)
Spontaneous abdominal hemorrhage with AA-amyloidosis and vasculitis in a patient with rheumatoid arthritis. (2001) (2)
Review: Vascular calcification in chronic kidney disease: the tip of the chalk-berg: (2008) (2)
Spontaneous and protracted partial remission of microscopic polyangiitis. (2002) (2)
Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia with a common immunophenotype (2)
Accelerated Progression of Calcific Aortic Stenosis in Dialysis Patients: What We Still Need to Learn (2003) (2)
VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Final Word: The Binders Wars 2007–2017: “The Truth is Out There Somewhere…” (2007) (2)
Organ calcification in renal hyperparathyroidism (1998) (2)
Waldenström's macroglobulinaemia presenting as isolated epistaxis: a common complaint but a rare cause (2004) (2)
FP357EFFECT OF RAAS BLOCKADE IN ADULTS WITH DIABETES MELLITUS AND ADVANCED CHRONIC KIDNEY DISEASE NOT ON DIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2015) (2)
Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis. (2003) (2)
Diabetes, tissue infarction, and calciphylaxis. (1997) (2)
New hope for chronic kidney disease patients after the JUPITER trial: myth or reality? (2010) (2)
Blood pressure in dialysis patients—look before we leap (2009) (2)
Long-term risks of increased use of intravenous iron (2007) (2)
Case report: making the CONN-ection: two cases of persistent hypertension and hypokalaemia following renal transplantation (2012) (2)
Images in clinical medicine. von Hippel-Lindau disease. (1999) (2)
Tingling extremities in a young man. (1996) (2)
Serious interaction between tacrolimus FK506 and chloramphenicol in a kidney–pancreas transplant recipient (2003) (2)
Hypertension and renal failure. (1998) (2)
Symptomatic cytomegalovirus infection complicating treatment of acute systemic vasculitis. (2004) (1)
Management of Renal Impairment (2003) (1)
Measuring Blood Pressure in Stable Renal Transplant Recipients: What You Measure Depends on What You Use (2004) (1)
Parathyroid Glands in Chronic Kidney Disease (2020) (1)
Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome (2013) (1)
Real-World, Cross-Sectional, Descriptive Study Of The Quality Of Life Of Patients With Anemia And Chronic Kidney Disease Across Europe (2016) (1)
The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic (2011) (1)
Atypical post-renal transplantation hyperparathyroidism--further support for "removing all enlarged glands". (2003) (1)
Uptake of biosimilar therapies--opportunities and obstacles. Commentary. (2006) (1)
Low Sodium Diet, Vitamin D, or Both for RAASi-Resistant, Residual, Proteinuria in CKD? The ViRTUE Trial Points the Way Forward but Is Not the Last Word. (2017) (1)
Detection of bowel cancer in kidney transplant recipients (2012) (1)
Blood pressure variability measurements. (2000) (1)
Cross-Sectional Descriptive Study Of The Impact Of Anaemia In Patients With Chronic Kidney Disease On Healthcare Resource Utilisation And Work Productivity Across Europe. (2015) (1)
Sudden cardiac death in chronic kidney disease (2015) (1)
Acute kidney injury – nephrology's latest problem child (2016) (1)
[The progression factors in autosomal dominant polycystic disease]. (1996) (1)
Serum ferritin concentrations in dialysis patients. (1996) (1)
Post transplant lymphoproliferative disorder (PTLD): A single centre clinicopathological study of 34 cases complicating solid organ renal transplants. (2003) (1)
Effect of Vitamin D on Endothelial Function and Blood Pressure (2015) (1)
HX 575 : established biosimilarity in the treatment of renal anemia and 10 years of clinical experience (2017) (1)
CKD GENERAL AND CLINICAL EPIDEMIOLOGY 2 (2014) (1)
Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury (2016) (1)
Faculty Opinions recommendation of FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. (2011) (1)
Eosinophilia and symptomatic pulmonary amyloidosis (2004) (1)
The EVOLVE study is negative, so what does this ‘bitter pill’ of disappointment mean now for renal patients? (2014) (1)
Laudable Pus – Lardaceous Kidneys (2002) (1)
Pulmonary embolism--or vasculitis? (2004) (1)
Examination of the Effect of Percutaneous Mechanical Thrombectomy on Acute Kidney Function, Following Intervention for Acute Iliofemoral Deep Venous Thrombosis (2019) (1)
Biology of vascular calcification in renal failure (2009) (1)
An Unusual Pyridine Nucleotide Accumulating in Erythrocytes: Its Identity and Positive Correlation with Degree of Renal Failure (2005) (1)
Infections in hemodialysis (2009) (1)
Nocturnal Hypertension in Dialysis Patients (1998) (1)
Direct renin inhibitors: ONTARGET for success? (2009) (1)
MO067LONG-TERM PULSE WAVE VELOCITY AND VO2PEAK OUTCOMES WITH 12 WEEKS OF AEROBIC OR RESISTANCE TRAINING IN KIDNEY TRANSPLANT RECIPIENTS: A FOLLOW-UP OF THE EXERT STUDY (2016) (1)
Protein-energy wasting (2013) (1)
Faculty Opinions recommendation of The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. (2013) (0)
Morbidity and mortality related to disturbances in mineral metabolism in CKD (2010) (0)
Renal anaemia - CKD 5D (2012) (0)
Skin Cancer and Immunosuppression Type in Long-Term Renal Transplant Recipients: A Case-Controlled Analysis.: Abstract# C1784 (2014) (0)
META-ANALYSIS OF THE IMPACT OF VITAMIN D RECEPTOR ACTIVATORS FOR REDUCTION OF PROTEINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE (2013) (0)
Renal Medicine : A Color Handbook (2004) (0)
Transplantation: clinical studies - A (2013) (0)
Predicting and Treating Abnormal Bone Mineral Density in Long-Term Renal Transplant Patients - Is There a Role for Measuring Vitamin D Status?: 1439 (2012) (0)
An unusual cause of peripheral neuropathy in a diabetic patient on dialysis: “a sural surprise” (2003) (0)
FP858FIRST REPORT OF THERAPEUTIC DRUG MONITORING OF AZATHIOPRINE IN LONG−TERM RENAL TRANSPLANT SURVIVORS − WHAT IS THE DESIRABLE RANGE TO TARGET? (2015) (0)
New markers and therapies for coronary artery disease in renal patients. (2002) (0)
PP-043 SERUM VITAMIN D LEVELS ARE INDEPENDENTLY ASSOCIATED WITH SEVERITY OF CORONARY ARTERY DISEASE (2012) (0)
Relationships between blood pressure variability and left ventricular parameters in haemodialysis and renal transplant patients (1998) (0)
Faculty Opinions recommendation of Cardiac resynchronization therapy in CKD: a systematic review. (2013) (0)
Faculty Opinions recommendation of Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. (2012) (0)
Inflammation and coronary calcification in renal patients--factors that may explain increased cardiovascular risk, and poorer results of coronary interventions? (2004) (0)
High Prevalence of Reduced Bone Mineral Density in Long Term Ambulant Renal Transplant Recipients- Is Bone Biochemistry a Useful Marker?: 1840 (2012) (0)
Opponent's comments. (2016) (0)
The Janus faces of ESAs: caveat Chimaera! (2013) (0)
Faculty Opinions recommendation of Aging augments IL-17 T-cell alloimmune responses. (2009) (0)
Diagnosis and management of bone problems in chronic kidney disease (2012) (0)
Reply to Chow et al. (Clin. Nephrol 60: 297) (2003) (0)
E. CKD EPIDEMIOLOGY SaO021 ISCHAEMIC STROKE, HAEMORRHAGE, AND MORTALITY IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE NEWLY STARTED ON ANTI-COAGULATION FOR ATRIAL FIBRILLATION-A POPULATION BASED STUDY FROM UK PRIMARY CARE (2018) (0)
141 Baseline Characteristics of Subjects in Impact-Shpt: A Study to Evaluate the Efficacy and Safety of Paricalcitol and Cinacalcet in Hemodialysis Patients With Secondary Hyperparathyroidism (2011) (0)
Biocompatible putty formulation for chronic and acute wounds (2011) (0)
Answers to the quiz on the previous page (2004) (0)
Full Reviews Urea and chronic kidney disease: the comeback of the century? (in uraemia research) (2018) (0)
Formulations antibiotiques d'application topique (2011) (0)
Faculty Opinions recommendation of Interventions for HIV-associated nephropathy. (2013) (0)
SaO021ISCHAEMIC STROKE, HAEMORRHAGE, AND MORTALITY IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE NEWLY STARTED ON ANTI-COAGULATION FOR ATRIAL FIBRILLATION - A POPULATION BASED STUDY FROM UK PRIMARY CARE (2018) (0)
DIALYSIS. EXTRACORPOREAL DIALYSIS: TECHNIQUES AND ADEQUACY FP473 THE USE OF HIGH-FLUXMEMBRANES IS NOTASSOCIATED WITH IMPROVED SURVIVALOF PATIENTS ON HEMODIALYSIS (2015) (0)
Dyslipidemia and Chronic Kidney Disease (2020) (0)
Is “Me, Me, Me” the New “We, We, We”?: Can We Afford (Not) to Take the Plunge into the Personalised, Stratified Medicine Era? (2015) (0)
ORGAN CALCIFICATION IN RENAL HYPERPARATHYROIDISM. AUTHOR'S REPLY (1998) (0)
Faculty Opinions recommendation of Change in cardiac geometry and function in CKD children during strict BP control: a randomized study. (2012) (0)
PUK20 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE VS. SEVELAMER HYDROCHLORIDE IN PATIENTS WITH END-STAGE RENAL DISEASE (2010) (0)
Faculty Opinions recommendation of Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. (2011) (0)
Polar Views in Nephrology Pro: Cardiovascular calcifications are clinically relevant (2015) (0)
Modern Management of Post-Transplant Anaemia - Focus on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) and IV Iron Therapies: 1276 (2012) (0)
ACE inhibitors for all—‘Hope’ for the heart and failure for the kidneys? (2001) (0)
SP399BENEFICIAL IMMUNOMODULATORY EFFECT OF CHOLECALCIFEROL REPLETION IN CKD PATIENTS : DOWN-REGULATION OF CELL SURFACE HLA-DR EXPRESSION MAY EXPLAIN REDUCTION IN INFLAMMATION (2015) (0)
Fatal and Serious Anaphylaxis Following Peginesatide Administration (2013) (0)
Full Reviews The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients (2017) (0)
P184 CHRONIC KIDNEY DISEASE IS COMMON IN THE SETTING OF A LARGE TERTIARY REFERRAL LIPID CLINIC (2010) (0)
Pulmonary Embolism–- or Vasculitis? (2004) (0)
High prevalence of cardiovascular disease risk factors, but inadequate risk factor interventions, in diabetic patients on dialysis or after renal transplantation. (2002) (0)
PARICALCITOL COMPARED TO CINACALCET WITH LOW-DOSE VITAMIN D THERAPY FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS RECEIVING HAEMODIALYSIS: RESULTS OF THE IMPACT SHPT RESEARCH (2013) (0)
Elective rather than emergency intervention for acute renal artery occlusion with anuria. (1994) (0)
Epidemiology - renal outcomes (2013) (0)
LEFT VENTRICULAR CONSEQUENCES OF RENAL TRANSPLANTATION AND CALCIUM-CHANNELBLOCKERS. AUTHORS' REPLY (1997) (0)
Faculty Opinions recommendation of Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. (2012) (0)
FP473THE USE OF HIGH-FLUX MEMBRANES IS NOT ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS ON HEMODIALYSIS (2015) (0)
Clinical outcomes with iron-based phosphate binders for CKD patients (2017) (0)
Faculty Opinions recommendation of Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials. (2013) (0)
Faculty Opinions recommendation of Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. (2007) (0)
Faculty Opinions recommendation of Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. (2013) (0)
Retraction of transplantation studies: journals should routinely question the source of organs (2019) (0)
Faculty Opinions recommendation of The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease. (2007) (0)
MP173 THE GERMAN CYLCIPHYLAXIS REGISTRY (2013) (0)
Control of Secondary Hyperparathyroidism (SPHT) by Older and Newer Vitamin D Compounds (2020) (0)
Anaemia in CKD 1-5 (2011) (0)
Faculty Opinions recommendation of Effect of early initiation of dialysis on cardiac structure and function: results from the echo substudy of the IDEAL trial. (2012) (0)
Mineral and bone disease - CKD 1-5 (2012) (0)
Left ventricular consequences of renal transplantation and calcium-channel blockers. (1997) (0)
Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis (2013) (0)
In order to improve CKD – MBD outcomes , in 2003 , the National Kidney Foundation launched the Kidney Dialysis (2012) (0)
THE NOVEL FIBROSIS MARKER GALECTIN 3 ASSOCIATES WITH INFECTIOUS DEATHS , ALL-CAUSEMORTALITY AND CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS (2013) (0)
F1000Prime recommendation of Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. (2012) (0)
TRANSPLANTATION : CLINICAL STUDIES-A SP 636 ENDOTHELIAL DYSFUNCTION IN RENALTRANSPLANT RECIPIENTS : ROLE OF VITAMIN D AND FIBROBLAST GROWTH FACTOR-23 (2013) (0)
Serious interaction between tacrolimus FK506 and chloramphenicol in a kidney‐pancreas transplant recipient (2003) (0)
SIMILAR INTRAVENOUS (I.V.) AND SUBCUTANEOUS (S.C.) WEEKLY ERYTHROPOETIN DOSES ARE REQUIRED TO MAINTAIN THE TARGET HAEMOGLOBIN IN IRON- REPLETED HAEMODIALYSIS PATIENTS WITH CORRECT ADJUVANT THERAPY: DATA FROM A PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL (2004) (0)
[Treating dyslipaemia in renal patients: evidences and implications]. (2009) (0)
SP55824-MONTH SAFETY OUTCOMES OF BIOSIMILAR EPOETIN ALFA IN THE EUROPEAN MONITOR-CKD5 PHARMACOEPIDEMIOLOGICAL STUDY OF ANAEMIA IN HAEMODIALYSIS (2016) (0)
ENDOLUMINAL BRUSHING OF BLOCKED INDWELLING HAEMODIALYSIS CATHETERS. AUTHORS' REPLY (1999) (0)
Cardiovascular disease and chronic kidney disease (2015) (0)
Corrigendum to “Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD)” [Bone 48 (2011) 1127–1132] (2011) (0)
a Case oF ReNaL tUBeRCULosIs pReseNtING as "spoNtaNeoUs" peRIReNaL HaeMoRRHaGe (2006) (0)
CORONARY ARTERY CALCIFICATION ON COMPUTED TOMOGRAPHY. AUTHORS' REPLY (1998) (0)
Relationships between volume status and blood pressure in haemodialysis patients--the long and the short of it? (1998) (0)
Faculty Opinions recommendation of Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. (2012) (0)
1010-135 Clopidogrel increases post cardiac surgery bleeding only if given within three days of surgery (2004) (0)
P181 ELEVATED TRIGLYCERIDE/HDL CHOLESTEROL RATIO IS A PREDICTOR OF POOR RENAL FUNCTION IN A LARGE TERTIARY REFERRAL LIPID CLINIC (2010) (0)
Faculty Opinions recommendation of Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. (2013) (0)
Sunday, May 11, 2008: Free Communications (2008) (0)
Reply to Jolobe. (2014) (0)
Leukocyte intracellular pH in uraemia and diabetes. (1992) (0)
MO059RISK FACTORS FOR SEVERE RENAL DISEASE IN BARDET-BIEDL SYNDROME - PHENOTYPIC AND GENOTYPIC ANALYSES OF THE LARGEST REPORTED AFFECTED COHORT (2016) (0)
Plasma Ouabain like Substance and Platelet Sodium Pump Activity in Chronic Renal Failure (2002) (0)
Faculty Opinions recommendation of Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. (2013) (0)
Renal transplantation - clinical studies - 2 (2009) (0)
How Well Do Renal Transplant Patients “Cover-Up”? Seasonal Vitamin D Variation in Long-Term Renal Transplant Survivors: 1279 (2012) (0)
FO031THE EFFECT OF AEROBIC OR RESISTANCE TRAINING ON VASCULAR HEALTH, CARDIO-RESPIRATORY FITNESS, QUALITY OF LIFE, PHYSICAL FUNCTION, AND INFLAMMATORY BIOMARKERS IN KIDNEY TRANSPLANT RECIPIENTS: A PILOT RANDOMISED CONTROLLED TRIAL - THE EXERT STUDY (2015) (0)
Dyslipidemia and the risk of end stage renal disease. (2004) (0)
What's in a blister? A diagnostic twister. (2004) (0)

This paper list is powered by the following services:

David J. A. Goldsmith's Academic­Influence.com Rankings

David J. A. Goldsmith's Degrees

Why Is David J. A. Goldsmith Influential?

David J. A. Goldsmith's Published Works

Published Works

David J. A. Goldsmith's AcademicInfluence.com Rankings